Doyle William J, Alper Cuneyt M
Department of Otolaryngology, Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Curr Opin Allergy Clin Immunol. 2007 Feb;7(1):11-6. doi: 10.1097/ACI.0b013e3280115157.
Most studies on the natural history of viral upper respiratory tract infections and their complications rely for ascertainment on self-assessed cold/flu illness or the identification of presumed complications. The criteria for cold/flu definition, however, are variable within and between individuals and illness is not prerequisite for a viral upper respiratory tract infection. These factors bias estimates of the incidence and prevalence of viral upper respiratory tract infections and their complications. Here we review new methodologies that can be adapted for use in future studies to refine those estimates.
We present a theoretical basis for standardized assignment of cold/flu episodes using a minimal algorithm template that operates on a structured set of symptoms/signs. We emphasize the greater accuracy of information derived from longitudinal studies that incorporate identification algorithms and assay of nasal secretions for causal virus by polymerase chain reaction and for proinflammatory chemicals to confirm nasal inflammation.
The methodologies and sampling strategies that we describe hold promise for better characterizing the incidence of complications for symptomatic and asymptomatic expressions of a viral upper respiratory tract infection caused by specific viruses. These data can then be used to estimate the efficacy and efficiency in a specified target population of prophylactic or intercurrent treatments to prevent the complications.
大多数关于病毒性上呼吸道感染及其并发症自然史的研究,在确定病例时依赖于自我评估的感冒/流感疾病或假定并发症的识别。然而,感冒/流感的定义标准在个体内部和个体之间存在差异,而且患病并非病毒性上呼吸道感染的先决条件。这些因素会影响对病毒性上呼吸道感染及其并发症发病率和患病率的估计。在此,我们回顾了一些新方法,这些方法可用于未来的研究,以完善这些估计。
我们提出了一个理论基础,用于使用基于结构化症状/体征集的最小算法模板对感冒/流感发作进行标准化分类。我们强调,通过纵向研究获得的信息具有更高的准确性,这些研究结合了识别算法,并通过聚合酶链反应检测鼻腔分泌物中的致病病毒以及检测促炎化学物质以确认鼻腔炎症。
我们描述的方法和抽样策略有望更好地描述由特定病毒引起的病毒性上呼吸道感染的有症状和无症状表现的并发症发生率。然后,这些数据可用于估计在特定目标人群中预防并发症的预防性或并发治疗的疗效和效率。